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Background
Mycobacterium tuberculosis infects 2 billion people
worldwide, 90% of infected individuals are able to resist
overt disease development and manifest only latent
infection. Myeloid derived suppressor cells (MDSCs) are
a heterogeneous population of early myeloid progeni-
tors, immature granulocytes, macrophages, and dendritic
cells at different stages of differentiation. These cells
have the capacity to suppress activities of adaptive
immune response mediated by CD4+ and CD8+ T cells.
Methods
The frequency of MDSC(CD45+CD14+HLA dR-), Granu-
locyte derived MDSC (CD45+CD33+HLA dR CD14
CD11b+) and Monocyte derived MDSC(CD45+CD33
+HLA dR CD14+CD11b+) was examined by using flow
cytometry in pulmonary tuberculosis (PTB)(n=115) and
compared with extra-pulmonary TB (ETB)(n=106), latent
TB (LTB)(n=102) and healthy controls (HC)(n=73)
Results
PTB is characterized by significantly elevated frequencies
of MDSC (Geometric mean [GM] of 0.5587% in PTB and
0.3095% in EP; p=0.0005); G-MDSC (GM of 0.1660% in
PTB and 0.3089% in EP; p=0.0189) and M-MDSC (GM of
0.1307% in PTB and 0.0756% in EP; p=0.0128) when com-
pared with ETB. On the other hand, there was diminished
frequency of MDSC (GM of 0.5587% in PTB and 1.064%
in LTB; p= 0.0060) (GM of 0.5587% in PTB and 1.187% in
HC; p<0.0001) and G-MDSC (GM of 0.1660% in PTB and
0.4131% in HC; p<0.0001) (GM of 0.1660% in PTB and
0.3516% in HC; p<0.0001) in PTB group when compared
with LTB and HC, respectively.
Conclusions
The data reveals that MDSC were not only induced during
active pulmonary TB infection but also in latent TB and
healthy controls after recent exposure to M. tuberculosis.
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